Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

ESMO Immuno Oncology Congress 2017

Start date: 07 Dec 2017
End date: 10 Dec 2017
Location: Geneva, Switzerland

Oncologists of today must adapt to rapid changes in practice. The promising results of immunotherapies in oncology are generating increasing interest from the oncology community and have the potential to become the standard of care.

This year saw the launch of the ESMO Immuno Oncology Congress, the new highly-focused meeting devoted entirely to the development and use of immunotherapies against cancer.

The creation of the ESMO Immuno Oncology Congress reflects ESMO’s commitment to providing oncologists who need to learn how to apply the latest standards of care in the immunotherapy of cancer with a comprehensive update in an environment rich with highly specialised professionals.